M&T Bank’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-99,234
Closed -$801K 1592
2024
Q4
$801K Buy
99,234
+14,097
+17% +$114K ﹤0.01% 977
2024
Q3
$873K Buy
85,137
+13,711
+19% +$141K ﹤0.01% 945
2024
Q2
$505K Buy
71,426
+21
+0% +$149 ﹤0.01% 1120
2024
Q1
$982K Sell
71,405
-12,521
-15% -$172K ﹤0.01% 885
2023
Q4
$772K Buy
83,926
+12,962
+18% +$119K ﹤0.01% 966
2023
Q3
$429K Buy
70,964
+104
+0.1% +$629 ﹤0.01% 1147
2023
Q2
$550K Buy
+70,860
New +$550K ﹤0.01% 1083
2022
Q1
Sell
-20,536
Closed -$302K 1526
2021
Q4
$302K Buy
20,536
+5,901
+40% +$86.8K ﹤0.01% 1246
2021
Q3
$306K Buy
+14,635
New +$306K ﹤0.01% 1224
2021
Q2
Sell
-9,153
Closed -$224K 1536
2021
Q1
$224K Hold
9,153
﹤0.01% 1364
2020
Q4
$310K Buy
9,153
+1,106
+14% +$37.5K ﹤0.01% 1319
2020
Q3
$201K Buy
8,047
+1,782
+28% +$44.5K ﹤0.01% 1422
2020
Q2
$211K Buy
+6,265
New +$211K ﹤0.01% 1357